Not Yet Recruiting A Scientific Evaluation of One or Two Doses of a Vaccine Against Human Papillomavirus: Long Term Follow Up of Gardasil9 Recipients in the ESCUDDO Study ("Estudio de Comparación de Una y Dos Dosis de Vacunas Contra el Virus de Papiloma Humano [VPH]") NCT07706673 Conditions Human Papillomavirus-Related Malignant Neoplasm Locations Agencia Costarricense de Investigaciones Biomédicas (ACIB) — Liberia, Guanacaste Province, Costa Rica View Trial Details
Active, Not Recruiting I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination NCT04452526 Conditions Cervical Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more Locations University of Kentucky/Markey Cancer Center — Lexington, Kentucky, United States Ohio State University Comprehensive Cancer Center — Columbus, Ohio, United States University of Virginia — Charlottesville, Virginia, United States West Virginia University — Morgantown, West Virginia, United States View Trial Details
Active, Not Recruiting Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study NCT03309033 Conditions Communicable Diseases, DNA Virus Infections, Disease Attributes, +12 more Locations Agencia Costarricense de Investigaciones Biomédicas (ACIB) — Liberia, Guanacaste Province, Costa Rica View Trial Details
